Active Concerns Wondering Movers: Pandora Media, Inc. (NYSE:P), KBR, Inc. (NYSE:KBR)

Shares of Pandora Media, Inc. (NYSE:P) [Trend Analysis] swings enthusiastically in regular trading session, it a gain of 6.58% to close at $12.79. Pandora Media Inc. (P) reported that it anticipates to report larger-than-predicted fourth-quarter sales on subscriber and advertising growth. The Oakland, Calif., based company also said it is planning layoffs and that it has surpassed 4.3 million paid subscribers.

Pandora aims to end 2017 with 7% fewer employees, the company said in a statement. Pandora is slated to report fourth-quarter and full-year results on Feb. 9. At the time it declared third-quarter results, Pandora said it expected fourth-quarter sales in the range of $362 million to $374 million. It expected an adjusted loss between $51 million and $39 million. Moving forward to saw long-term intention, the experts calculate Return on Investment of -17.20%. The stock is going forward its fifty-two week low with 80.14% and lagging behind from its 52-week high price with -14.62%. P last month stock price volatility remained 2.94%.

KBR, Inc. (NYSE:KBR) [Trend Analysis] retains strong position in active trade, as shares scoring -0.77% to $16.78 in a active trade session, while looking at the shares volume, around 61809 shares have changed hands in this session. KBR, Inc. (NYSE:KBR) recently declared that it will host a conference call to discuss its fourth quarter and fiscal 2016 financial results on Friday, February 24, 2017 at 8 a.m. Central Time (9 a.m. Eastern Time). The company plans to issue its fourth quarter 2016 earnings release and earnings presentation in advance of the call. Both the earnings release and presentation will be accessible on KBR’s website. The call will be webcast and can be accessed through the KBR website at under the Investor Relations section. The firm has institutional ownership of 98.90%, while insider ownership included 0.30%. KBR attains analyst recommendation of 2.30 with week’s performance of -1.69%. Investors looking further ahead will note that the Price to next year’s EPS is 201.35%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *